{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T09:49:51Z","timestamp":1777196991638,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Urol Rep"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.1007\/s11934-996-0008-y","type":"journal-article","created":{"date-parts":[[2007,6,7]],"date-time":"2007-06-07T14:16:35Z","timestamp":1181225795000},"page":"288-292","source":"Crossref","is-referenced-by-count":81,"title":["Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia"],"prefix":"10.1007","volume":"7","author":[{"given":"Sanjay","family":"Kasturi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shane","family":"Russell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin T.","family":"McVary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"8_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1159\/000052430","volume":"39","author":"J Hammarsten","year":"2001","unstructured":"Hammarsten J, Hogstedt B: Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur Urol 2001, 39:151\u2013158.","journal-title":"Eur Urol"},{"key":"8_CR2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1249\/01.MSS.0000079076.74931.9A","volume":"35","author":"TA Lakka","year":"2003","unstructured":"Lakka TA, Laaksonen DE, Lakka HM, et al.: Sedentary lifestyle, poor cardiorespiratory fitness, and the metabolic syndrome. Med Sci Sports Exerc 2003, 35:1279\u20131286.","journal-title":"Med Sci Sports Exerc"},{"key":"8_CR3","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jama.287.3.356","volume":"287","author":"ES Ford","year":"2002","unstructured":"Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356\u2013359. Excellent summary of the MSx epidemic in the United States.","journal-title":"JAMA"},{"key":"8_CR4","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2337\/diacare.28.3.690","volume":"28","author":"S Malik","year":"2005","unstructured":"Malik S, Wong ND, Franklin S, et al.: Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 2005, 28:690\u2013693.","journal-title":"Diabetes Care"},{"key":"8_CR5","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/j.amjcard.2005.11.010","volume":"97","author":"SM Haffner","year":"2006","unstructured":"Haffner SM: The metabolic syndrome: inflammation, diabetes mellitus, and cardiovascular disease. Am J Cardiol 2006, 97:3A-11A.","journal-title":"Am J Cardiol"},{"key":"8_CR6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00125-005-1798-z","volume":"48","author":"G Grassi","year":"2005","unstructured":"Grassi G, Dell\u2019Oro R, Quarti-Trevano F, et al.: Neuroadrenergic and reflex abnormalities in patients with metabolic syndrome. Diabetologia 2005, 48:1359\u20131365.","journal-title":"Diabetologia"},{"key":"8_CR7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1056\/NEJM199602083340607","volume":"334","author":"GM Reaven","year":"1996","unstructured":"Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996, 334:374\u2013381.","journal-title":"N Engl J Med"},{"key":"8_CR8","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/00004872-200103001-00001","volume":"19","author":"L Landsberg","year":"2001","unstructured":"Landsberg L: Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 2001, 19:523\u2013528. A clear description of the etiology of sympathetic hyperactivity in metabolic syndrome.","journal-title":"J Hypertens"},{"key":"8_CR9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.ju.0000173072.73702.64","volume":"174","author":"KT McVary","year":"2005","unstructured":"McVary KT, Rademaker A, Lloyd GL, Gann P: Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J Urol 2005, 174:1327\u20131433. Clear demonstration of the relationship between MSx and LUTS\/BPH.","journal-title":"J Urol"},{"key":"8_CR10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1095\/biolreprod51.1.99","volume":"51","author":"KT McVary","year":"1994","unstructured":"McVary KT, Razzaq A, Lee C, et al.: Growth of the rat prostate gland is facilitated by the autonomic nervous system. Biol Reprod 1994, 51:99\u2013107.","journal-title":"Biol Reprod"},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/j.1939-4640.2000.tb03276.x","volume":"21","author":"E Golomb","year":"2000","unstructured":"Golomb E, Rosenzweig N, Eilam R, Abramovici A: Spontaneous hyperplasia of the ventral lobe of the prostate in aging genetically hypertensive rats. J Androl 2000, 21:58\u201364.","journal-title":"J Androl"},{"key":"8_CR12","first-page":"78","volume":"121","author":"RJ Glynn","year":"1985","unstructured":"Glynn RJ, Campion EW, Bouchard GR, Silbert JE: The development of benign prostatic hyperplasia among volunteers in the Normative Aging Study. Am J Epidemiol 1985, 121:78\u201390.","journal-title":"Am J Epidemiol"},{"key":"8_CR13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1080\/080370599438365","volume":"8","author":"J Hammarsten","year":"1999","unstructured":"Hammarsten J, Hogstedt B: Clinical, anthropometric, metabolic and insulin profile of men with fast annual growth rates of benign prostatic hyperplasia. Blood Press 1999, 8:29\u201336.","journal-title":"Blood Press"},{"key":"8_CR14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1469-445X.1999.tb00079.x","volume":"84","author":"WD Steers","year":"1999","unstructured":"Steers WD, Clemow DB, Persson K, et al.: The spontaneously hypertensive rat: insight into the pathogenesis of irritative symptoms in benign prostatic hyperplasia and young anxious males. Exp Physiol 1999, 84:137\u2013147.","journal-title":"Exp Physiol"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0895-4356(01)00351-1","volume":"54","author":"JB Meigs","year":"2001","unstructured":"Meigs JB, Mohr B, Barry MJ, et al.: Risk factors for clinical benign prostatic hyperplasia in a community-based population of healthy aging men. J Clin Epidemiol 2001, 54:935\u2013944.","journal-title":"J Clin Epidemiol"},{"key":"8_CR16","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","volume":"349","author":"JD McConnell","year":"2003","unstructured":"McConnell JD, Roehrborn CG, Bautista OM, et al.: Medical Therapy of Prostatic Symptoms (MTOPS) Research Group. The long-term effects of doxazosin, finasteride, and the combination on the clinical progression of BPH. N Engl J Med 2003, 349:2387\u20132398.","journal-title":"N Engl J Med"},{"key":"8_CR17","first-page":"241","volume":"171","author":"CG Roehrborn","year":"2004","unstructured":"Roehrborn CG, McConnell JD, Kusek J, et al.: Impact of baseline PSA and TRUS volume on longitudinal changes in IPSS and maximum flow rate in MTOPS [Abstract 910]. J Urol 2004, 171:241.","journal-title":"J Urol"},{"key":"8_CR18","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/sj.pcan.4500221","volume":"1","author":"J Hammarsten","year":"1998","unstructured":"Hammarsten J, Hogstedt B, Holthuis N, Mellstrom D:Components of the metabolic syndrome-risk factors for the development of benign prostatic hyperplasia. Prostate Cancer Prostatic Dis 1998, 1:157\u2013162.","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"8_CR19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/pros.2990260109","volume":"26","author":"PH Gann","year":"1995","unstructured":"Gann PH, Hennekens CH, Longcope C, et al.: A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 1995, 26:40\u201349.","journal-title":"Prostate"},{"key":"8_CR20","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1002\/ijc.21668","volume":"118","author":"LD Maso","year":"2006","unstructured":"Maso LD, Zucchetto A, Tavani A, et al.: Lifetime occupational and recreational physical activity and risk of benign prostatic hyperplasia. Int J Cancer 2006, 118:2632\u20132635.","journal-title":"Int J Cancer"},{"key":"8_CR21","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/ije\/30.2.341","volume":"30","author":"JV Lacey","year":"2001","unstructured":"Lacey JVJr, Deng J, Dosemeci M, et al.: Prostate cancer, benign prostatic hyperplasia, and physical activity in Shanghai, China. Int J Epidemiol 2001, 30:341\u2013349.","journal-title":"Int J Epidemiol"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1001\/archinte.158.21.2349","volume":"158","author":"EA Platz","year":"1998","unstructured":"Platz EA, Kawachi I, Rimm EB, et al.: Physical activity and benign prostatic hyperplasia. Arch Intern Med 1998, 158:2349\u20132356. Excellent paper detailing the risk of physical inactivity and the development of LUTS.","journal-title":"Arch Intern Med"},{"key":"8_CR23","doi-asserted-by":"crossref","first-page":"2887","DOI":"10.1016\/j.ejca.2005.09.003","volume":"41","author":"J Hammarsten","year":"2005","unstructured":"Hammarsten J, Hogstedt B: Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Can 2005, 41:2887\u20132895.","journal-title":"Eur J Can"},{"key":"8_CR24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/pros.20110","volume":"62","author":"S Rohrmann","year":"2005","unstructured":"Rohrmann S, De Marzo AM, Smit E, et al.: Serum Creactive protein concentration and lower urinary tract symptoms in older men in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate 2005, 62:27\u201333.","journal-title":"Prostate"}],"container-title":["Current Urology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-996-0008-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11934-996-0008-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11934-996-0008-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T22:34:14Z","timestamp":1707950054000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11934-996-0008-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":24,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s11934-996-0008-y","relation":{},"ISSN":["1527-2737","1534-6285"],"issn-type":[{"value":"1527-2737","type":"print"},{"value":"1534-6285","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}